DAVID MOATAZEDI - 07 Dec 2023 Form 4 Insider Report for BIOMERICA INC (BMRA)

Role
Director
Signature
/s/ David Moatazedi
Issuer symbol
BMRA
Transactions as of
07 Dec 2023
Transactions value $
$0
Form type
4
Filing time
11 Dec 2023, 17:23:50 UTC
Previous filing
08 Dec 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMRA Common stock 0 07 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRA Non-qualified stock option Award +25,000 25,000 20 Apr 2023 Common Stock 25,000 $1.67 Direct F1, F3, F4
transaction BMRA Non-qualified stock option Award +32,000 32,000 20 Apr 2023 Common Stock 32,000 $1.67 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted to Mr. Moatazedi in April 2023 as a new Board member. Final issuance of the options was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023.
F2 Options granted to Mr. Moatazedi in April 2023 as part of his fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023.
F3 25% vesting on 12/7/2023, 25% on 12/07/2024, 25% on 12/07/2025 and 25% on 12/07/2026
F4 Not Applicable